| human | Q5 |
| P10058 | IRIS UNIBO author ID | 01680 |
| P496 | ORCID iD | 0000-0001-9479-5307 |
| P1153 | Scopus author ID | 7005431799 |
| P734 | family name | Gionchetti | Q100521848 |
| Gionchetti | Q100521848 | ||
| Gionchetti | Q100521848 | ||
| P735 | given name | Paolo | Q15731774 |
| Paolo | Q15731774 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q69598427 | 5-Aminosalicylic acid suppositories in the management of ulcerative colitis |
| Q57012796 | A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial |
| Q34998108 | Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study |
| Q44611787 | Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease |
| Q46709195 | Adult attachment and early parental experiences in patients with Crohn's disease. |
| Q45899366 | Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. |
| Q57000152 | Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet |
| Q57003782 | Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases |
| Q34504027 | Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. |
| Q36404946 | Antimicrobials in the management of inflammatory bowel disease |
| Q48070595 | Attachment and quality of life in patients with inflammatory bowel disease |
| Q33231186 | Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. |
| Q74836725 | Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis |
| Q79905651 | Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study |
| Q49065584 | Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing |
| Q56997939 | CT-guided percutaneous pelvic abscess drainage in Crohn's disease |
| Q44492047 | CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. |
| Q35555687 | Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease |
| Q54268605 | Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. |
| Q56985631 | Clinical course of microscopic colitis in a single-center cohort study |
| Q84415758 | Clinical guidelines for the management of pouchitis |
| Q74336990 | Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis |
| Q70587249 | Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of X-ray-demonstrated lesions of Crohn's disease |
| Q56995097 | Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis |
| Q46970183 | Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy |
| Q35078337 | Diagnosis and treatment of pouchitis |
| Q43659057 | Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon |
| Q30778152 | Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort |
| Q72894388 | Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients |
| Q68211300 | Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis |
| Q38258954 | European evidence based consensus on surgery for ulcerative colitis |
| Q34564902 | European evidence based consensus on the diagnosis and management of Crohn's disease: current management. |
| Q82963217 | European evidence-based Consensus on the management of ulcerative colitis: Special situations |
| Q37162458 | Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis |
| Q39906288 | Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. |
| Q44577941 | Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? |
| Q42674728 | Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. |
| Q47996752 | Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. |
| Q43606551 | Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls |
| Q41684197 | Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. |
| Q43353488 | High-dose probiotics for the treatment of active pouchitis |
| Q56973177 | IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis |
| Q44278497 | Ileal pouchitis-related arthritis. |
| Q57003105 | Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells |
| Q46189696 | Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis |
| Q30581062 | Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. |
| Q51612372 | Implications of antioxidant enzymes in human gastric neoplasms. |
| Q81230817 | Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study |
| Q44854180 | Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection |
| Q39975422 | Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. |
| Q34528521 | Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. |
| Q74082667 | Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis |
| Q38204130 | Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease |
| Q57000195 | Local injection of Infliximab for the treatment of perianal Crohn's disease |
| Q85043141 | Local injection of adalimumab for perianal Crohn's disease: better than infliximab? |
| Q36108499 | Management of inflammatory bowel disease: does rifaximin offer any promise? |
| Q34551989 | Management of pouch dysfunction or pouchitis with an ileoanal pouch |
| Q72048481 | Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches |
| Q43816718 | Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center |
| Q43442244 | Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease |
| Q48368011 | New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study. |
| Q46591734 | Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. |
| Q51527493 | Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. |
| Q44006203 | Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. |
| Q44488900 | Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. |
| Q48102465 | Oral beclomethasone dipropionate in chronic refractory pouchitis |
| Q56995231 | Oral budesonide in the treatment of chronic refractory pouchitis |
| Q56989549 | Parental bonding and inflammatory bowel disease |
| Q43127800 | Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease |
| Q67721104 | Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease |
| Q43214835 | Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease. |
| Q62732106 | Potential role for the common cystic fibrosis ΔF508 mutation in Crohnʼs disease |
| Q48187847 | Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease. |
| Q90744326 | Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics |
| Q45741361 | Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. |
| Q38442953 | Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression |
| Q81581289 | Probiotic therapy to prevent pouchitis onset |
| Q35542640 | Probiotics for the treatment of postoperative complications following intestinal surgery |
| Q33939743 | Probiotics in infective diarrhoea and inflammatory bowel diseases. |
| Q77375025 | Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? |
| Q57005215 | Probiotics--role in inflammatory bowel disease |
| Q43363077 | Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial |
| Q77942848 | Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance |
| Q41696055 | Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. |
| Q73300662 | Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? |
| Q56354430 | Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis |
| Q50942285 | Rescue therapy: ciclosporin or infliximab? |
| Q72301082 | Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission |
| Q69995055 | Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis |
| Q36589416 | Review article: aminosalicylates for distal colitis. |
| Q74562312 | Rifaximin systemic absorption in patients with ulcerative colitis |
| Q61908019 | Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease |
| Q44766663 | Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs. |
| Q34831072 | Role of conventional therapies in the era of biological treatment in Crohn's disease |
| Q68290791 | Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation |
| Q38049779 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations |
| Q61907980 | Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española) |
| Q34588754 | Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. |
| Q50857950 | Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding. |
| Q67975447 | Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis |
| Q44626888 | Standard treatment of ulcerative colitis |
| Q80490208 | Sympathetic hyperactivity in patients with ulcerative colitis |
| Q38230162 | Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism |
| Q85034775 | The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease |
| Q43738965 | The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. |
| Q42528303 | The effect of transient intestinal ischemia on inflammatory parameters. |
| Q46805368 | The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease |
| Q38185703 | The role of Budesonide-MMX in active ulcerative colitis |
| Q38552422 | The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis |
| Q46368289 | Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial |
| Q68520334 | Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial |
| Q56995480 | Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent |
| Q56959747 | Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease |
| Q59120549 | VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis |
| Q36220440 | VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics |
| Q44231461 | Variable response to probiotics in two models of experimental colitis in rats. |
| Q60023464 | Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease-An IG-IBD Study |
| Q72692183 | p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis |
Search more.